Oncology Medications

IBRANCE

Ibrance® (palbociclib) Is Available From Onco360

The limited distribution breast cancer medication can only be ordered from certain pharmacies.

IBRANCE Indications

IBRANCE is an oral oncology medication that is F.D.A. approved for two indications for certain breast cancer patients.  As a limited distribution medication, IBRANCE is only available from a small number of pharmacies.

APPROVED
INDICATIONS
DOSAGE FORM & STRENGTHS
IBRANCE is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:
• letrozole as initial endocrine based therapy in postmenopausal women, OR
• fulvestrant in women with disease progression following endocrine therapy1
125 mg, 100 mg, and 75 mg
oral capsules1